Follow The Filings

KIDS Orthopediatrics Corporation

Health Care, filed as ORTHOPEDIATRICS CORP (COM), Equity As of 2026 Q2 among managers we track Quote on Google Finance, opens in a new tab

Bought by 1 manager in 2026 Q2

  • 1 Owner
  • Max 0.7%
  • $3.6M
  • 1 add

In 2026 Q2 Nathan Fischel added to Orthopediatrics.

Who owns this now

Largest portfolio weights among holders, up to 0.7% (Nathan Fischel, Dafna Capital Management). Not free-float ownership.

  1. Nathan Fischel Add 0.69%

Who owns KIDS

Sorted by value, long equity only, as of 2026 Q2.

History
Nathan Fischel, Dafna Capital Management 0.69%, was 0.35% Add +97.7% 189,130 $3.6M History

1 current, options excluded

Weight bar: held both quarters added sold at this quarter’s reported price

Insider trades

Open-market buys and sales by KIDS's executives, directors and 10% owners in the last 12 months, from their Form 4s

All KIDS insider trades
  • None no insider bought on the open market
  • $46.7M sold by 3 insiders outside a trading plan
  • None no planned (10b5-1) sales
  1. Squadron Capital LLC 10% owner, +1 joint filer
    Sale
    $6.4M 302,369 shares at $21.01 4.6% of stake
    Traded Sep 10 Filed Sep 11
    ↗
  2. David R Pelizzon Director
    Sale
    $525K 22,500 shares at $23.35 0.3% of stake
    Traded Sep 2 Filed Sep 4
    ↗
  3. David R Pelizzon Director
    Sale
    $7.8M 336,831 shares at $23.04 4.9% of stake
    Traded Aug 28–Sep 1 Filed Sep 1
    ↗
  4. David R Pelizzon Director
    Sale
    $943K 38,300 shares at $24.63 0.6% of stake
    Traded Aug 24–26 Filed Aug 26
    ↗

Also filed in the last 12 months, not counted as buying or selling: 15 stock grants, 5 sales to cover taxes, and 2 gifts.

SEC filings

Recent issuer filings from EDGAR, 13 shown.

Filed Form Detail Links
SCHEDULE 13D/A — Filing Doc
SCHEDULE 13D/A — Filing Doc
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
8-K 7.01,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 5.07 Filing Doc
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
8-K 7.01,9.01 Filing Doc
DEF 14A Filing Doc
DEFA14A Filing Doc
8-K 1.01,2.03,9.01 Filing Doc

Source: SEC EDGAR submissions, updated 6 days ago. All on EDGAR

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025
Revenue $148.73M $204.73M $236.35M
Gross profit $111.25M $148.6M $172.66M
Gross margin * 74.8% 72.6% 73.1%
Net income -$20.97M -$37.82M -$39.65M
Net margin * -14.1% -18.5% -16.8%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $226.5M $237.17M $256.42M
Total non-current assets * $212.25M $236.04M $252.21M
Total assets $438.74M $473.21M $508.63M
Total current liabilities $41.67M $33.96M $46.2M
Total non-current liabilities $20.05M $84.68M $115.84M
Total equity $377.02M $354.57M $346.6M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$27.05M -$27.05M -$4.85M
Cash from investing $41.68M -$13.16M -$43.63M
Cash from financing $7.3M $53.14M $23.98M
Net change in cash $22.56M $12.75M -$24.16M

Source: SEC companyfacts (US-GAAP 10-K). A * marks a computed figure, not a single XBRL tag. Fiscal years are as the issuer labels them. Follow The Filings does not adjust or audit these figures.

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.